NEBZMART IL SMARTULE is a combination of Ipratropium and Levosalbutamol which belongs to the group of medicines called Bronchodilator agents and Adrenergic beta-agonists, respectively. NEBZMART IL SMARTULE is used to manage bronchospasm (tightened airway muscles) associated with chronic obstructive pulmonary disease (inflammatory lung disease) in patients who require more than one bronchodilator (medication) to help them in easy of breathing. NEBZMART IL SMARTULE is not recommended for use in patients allergic to ipratropium, levosalbutamol, and/or atropine. Before using NEBZMART IL SMARTULE, inform your doctor if you have high blood pressure, seizures, diabetes, narrow angle glaucoma (increased eye pressure), lung problems (such as asthma), heart problems (such as coronary insufficiency, cardiac arrhythmias), kidney problems (such as renal impairment), and/or liver problems (such as hepatic impairment). NEBZMART IL SMARTULE should be used with caution during pregnancy and in women planning for pregnancy. It is also used with caution in breastfeeding women only if necessary. NEBZMART IL SMARTULE is not recommended for use in children (aged less than 6 years). It should be used with caution in children and adolescents (aged 6 to 18 years). Consult your doctor before administering NEBZMART IL SMARTULE. The most common side effects of using NEBZMART IL SMARTULE are headache, dizziness, nervousness, cough, sore throat, local irritation, dry mouth, nausea, and/or diarrhoea. Consult your doctor if any of these symptoms worsens.
No content available
